1
|
Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.
|
J Cell Sci
|
2002
|
4.25
|
2
|
Evidence for a stem cell hierarchy in the adult human breast.
|
J Cell Biol
|
2007
|
3.76
|
3
|
Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.
|
BMJ
|
2005
|
3.21
|
4
|
Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer.
|
J Natl Cancer Inst
|
2009
|
2.28
|
5
|
Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma.
|
Am J Pathol
|
2003
|
2.06
|
6
|
Improving the reproducibility of diagnosing micrometastases and isolated tumor cells.
|
Cancer
|
2005
|
1.91
|
7
|
Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.
|
Mol Cell Proteomics
|
2004
|
1.57
|
8
|
Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer.
|
Int J Cancer
|
2007
|
1.53
|
9
|
Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol.
|
Acta Oncol
|
2008
|
1.47
|
10
|
Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions.
|
Mol Cell Proteomics
|
2005
|
1.32
|
11
|
Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor.
|
Int J Cancer
|
2007
|
1.24
|
12
|
A role for ADAM12 in breast tumor progression and stromal cell apoptosis.
|
Cancer Res
|
2005
|
1.24
|
13
|
Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.
|
Proc Natl Acad Sci U S A
|
2012
|
1.21
|
14
|
Urokinase receptor-associated protein (uPARAP) is expressed in connection with malignant as well as benign lesions of the human breast and occurs in specific populations of stromal cells.
|
Int J Cancer
|
2002
|
1.12
|
15
|
Performance of clinical mammography: a nationwide study from Denmark.
|
Int J Cancer
|
2006
|
1.11
|
16
|
Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
|
Mol Oncol
|
2009
|
1.07
|
17
|
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.
|
Am J Pathol
|
2003
|
1.05
|
18
|
Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment.
|
Am J Pathol
|
2010
|
1.01
|
19
|
Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.
|
Mol Oncol
|
2009
|
0.99
|
20
|
Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis.
|
Proteomics
|
2008
|
0.95
|
21
|
Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker.
|
J Proteome Res
|
2010
|
0.93
|
22
|
A model for determining the effect of mammography service screening.
|
Acta Oncol
|
2005
|
0.92
|
23
|
Towards discovery-driven translational research in breast cancer.
|
FEBS J
|
2005
|
0.90
|
24
|
Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.
|
FEBS Lett
|
2006
|
0.89
|
25
|
Breast cancer incidence, case-fatality and breast cancer mortality in Danish women using hormone replacement therapy--a prospective observational study.
|
Int J Epidemiol
|
2005
|
0.89
|
26
|
A single lysis solution for the analysis of tissue samples by different proteomic technologies.
|
Mol Oncol
|
2008
|
0.88
|
27
|
Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study.
|
Breast Cancer Res Treat
|
2002
|
0.88
|
28
|
A comparison of reproductive risk factors for CIS lesions and invasive breast cancer.
|
Int J Cancer
|
2004
|
0.88
|
29
|
15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma.
|
Mol Cell Proteomics
|
2008
|
0.88
|
30
|
Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
|
PLoS One
|
2008
|
0.87
|
31
|
Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
|
Mol Oncol
|
2007
|
0.84
|
32
|
Imaging of metastatic lymph nodes by X-ray phase-contrast micro-tomography.
|
PLoS One
|
2013
|
0.83
|
33
|
Invasive lobular breast cancer. Prognostic significance of histological malignancy grading.
|
Acta Oncol
|
2007
|
0.82
|
34
|
Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.
|
Mol Oncol
|
2010
|
0.82
|
35
|
DNA copy number aberrations in breast cancer by array comparative genomic hybridization.
|
Genomics Proteomics Bioinformatics
|
2009
|
0.80
|
36
|
Performance of combined clinical mammography and needle biopsy: a nationwide study from Denmark.
|
APMIS
|
2006
|
0.79
|
37
|
Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.
|
Mol Oncol
|
2007
|
0.79
|
38
|
Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.
|
Mol Cell Proteomics
|
2005
|
0.79
|
39
|
Breast cancer in situ. From pre-malignant lesion of uncertain significance to well-defined non-invasive malignant lesion. The Danish Breast Cancer Cooperative Group Register 1977-2007 revisited.
|
Acta Oncol
|
2008
|
0.75
|